Stockreport

Albireo Enrolls First Patient in Phase 3 PFIC Trial of A4250

Albireo Pharma, Inc.  (ALBO) 
Last albireo pharma, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.albireopharma.com/investor-relations
PDF — Pivotal program in rare and life-threatening pediatric liver disorder underway — — Data intended to provide support for anticipated drug approval applications in US a [Read more]